CTRI/2020/10/028279
Not yet recruiting
未知
Homeopathy as adjuvant to standard treatment protocol in management of corona virus infection- a randomized, placebo controlled, open label study
Central Council for Research in Homeopathy Ministry Ministry of Ayush0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- Central Council for Research in Homeopathy Ministry Ministry of Ayush
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \> 18 years
- •2\. All sexes
- •3\. Case definitions for inclusion in the study will include moderate and severe cases as defined in the Guidance on appropriate treatment of suspect/confirmed case of COVID19 issued by Ministry of Health and Family Welfare, Govt of India on 07 Apr 2020\.
- •a. Moderate: Pneumonia with no signs of severe disease (Respiratory Rate 15 to 30/minute, SpO2 90%\-94%).
- •b. Severe: Severe Pneumonia (with respiratory rate \< 30/minute and/or SpO2 and requiring non\-invasive ventilatory support
- •4\. Laboratory confirmed SARS CoV\-2 infection within last 10 days or SARS
- •5\. CoV\-2 test result pending with a high clinical suspicion as defined by:
- •a. Cough of \<10d duration
- •b. Bilateral pulmonary infiltrates on chest X Ray / CT scan or new hypoxaemia defined as SpO2 \<94% on room air
- •c. No alternative explanation for respiratory symptoms
Exclusion Criteria
- •1\. Children \< 18 years
- •2\. Covid Positive patients with severe co\-morbidities
- •3\. Pregnant and lactating women, infants and neonates
- •4\. Not willing to give consent for adjuvant treatment
- •5\. Inability to be contacted on D14 for clinical outcome assessment (unless died in hospital)
- •6\. In the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments.
- •7\. Symptoms of acute respiratory tract infection for \> 10d before randomisation, and covid status unknown
- •8\. Death within 24 Hrs. of admission
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Homoeopathy management for covid 19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J708- Respiratory conditions due to other specified external agentsCTRI/2020/09/028046Central Council for Research in Homeopathy Ministry Ministry of Ayush
Not yet recruiting
Phase 3
Comparative study of Homoeopathy as add on therapy to standard medicalmanagement in persons with Haemophilia (PWH)Health Condition 1: D67- Hereditary factor IX deficiencyHealth Condition 2: D66- Hereditary factor VIII deficiencyCTRI/2019/09/021435CCRH
Not yet recruiting
Phase 3
Pragmatic study of Homoeopathy as adjuvant therapy given along with standard medical management in Persons with Hemophilia and other bleeding disordersCTRI/2020/03/024357CCRH
Not yet recruiting
Not Applicable
Role of Homoeopathy in the treatment of Thyroid related disorders- HypothyroidismHealth Condition 1: E03- Other hypothyroidismCTRI/2022/05/042472Bakson Homoeopathic Medical College and Hospital
Not yet recruiting
Not Applicable
Individualized Homoeopathy as adjuvant therapy to nonsurgical periodontal treament in patients with chronic periodontitisHealth Condition 1: K053- Chronic periodontitisCTRI/2020/06/026254DrVHDave Homoeopathic Medical College